Modern Homeopathy has shown that it can significantly assist patients since: It can enhance the action of the chemical medications used to control their chronic symptoms
Entry point for public reimbursement Using the reduced off-patent price as a strong argument for increased access, Canada could become the first market with wide-scale reimbursement of existing primary care medicines, including GLP-1s for diabetes, to designate off-patent semaglutide as the first-line anti-obesity medication (AOM)
The TRIUMPH-4 trial reported percent body weight changes of -26.4% at the 9mg dose and -28.7% at the 12mg dose, compared to just -2.1% with placebo
Even if Intrinsic Factor is lacking, the sheer concentration of the liquid forces approximately 1-2% of the dose directly into the bloodstream, ensuring adequate delivery to the tissues
These symptoms can be non-specific and may be mistakenly attributed to gastrointestinal side effects commonly associated with GLP-1 agonists, such as nausea or dyspepsia